TKIs work by binding to the ATP-binding site of tyrosine kinases, thereby preventing the phosphorylation of tyrosine residues on target proteins. This inhibition stops the downstream signaling pathways that lead to cell proliferation and survival. By blocking these pathways, TKIs can effectively reduce tumor growth and spread.
